TLIS Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan Talis Biomedical

Efficient delivery of rapid diagnostic kits ensures the promptness of medical care for Talis Biomedical (TLIS). The quarterly earnings per share growth rate confirms the resilience of this model, where 41.70 serves as the current parameter value. The modernization of cartridge assembly shops eliminates operational disruptions, while the integration of AI into portable systems automates infection detection, minimizing human error during analysis.

Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan talis.bio (TLIS): kanggo periode 04.07.2022 - 07.09.2024

Rincian metrik komprehensif lan analitis Talis Biomedical (TLIS)

- rega saham lan prakiraan rega para ahli:

Rega saham talis.bio|TLIS - Target konsensus

- data kapitalisasi pasar:

Biji pasar Talis Biomedical Corp|TLIS - Nilai Dipunlarasaken Utang lan Kas

- indikator kapitalisasi buku:

Aset Bersih saben Siji Saham Talis Biomedical|TLIS - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku talis.bio|TLIS - Aset Perusahaan

- rincian struktur utang lan likuiditas bisnis:

Total Utang marang Modal Talis Biomedical|TLIS - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang modal talis.bio|TLIS - Gunggung kewajiban utang perusahaan|Utang-utang marang kapitalisasi buku Talis Biomedical Corp|TLIS - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Talis Biomedical|Likuiditas cepet talis.bio

- rincian bathi lan kelipatan pasar:

TLIS - Bathi resik perusahaan|Bathi mangsa ngarep Talis Biomedical|TLIS - Nilai perusahaan marang bathi resik|Pangali Forward P/E talis.bio|TLIS - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Talis Biomedical Corp|TLIS - Bathi operasional sadurunge potongan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Talis Biomedical|TLIS - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan talis.bio|TLIS - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Talis Biomedical

Analisis kabeh metrik perusahaan:Talis Biomedical Corp. - TLIS

This indicator measures the year-over-year quarterly dynamics of earnings per share, allowing investors to filter out market noise and assess the actual resilience of the business. Analyzing the quarterly growth of earnings per share reveals the cost management efficiency of Talis Biomedical (TLIS), where rising operational expenditures on IT infrastructure could offset the benefits of rapid diagnostics amid fierce competition.

Pesaing utama